New research coordinated from Queen Mary University of London, and with the participation of Juan de Dios Cañete, Julio Ramírez and Raquel Celis, researchers of the IDIBAPS Inflammatory joint diseas...
Patients with coexisting autoimmune disorders were generally excluded from checkpoint inhibitor (CPI) trials due to concerns over toxicity. A small cohort study suggests this patient group can safely ...
Rheumatology Services investigators and Molecular Genetics Unit of Marqués de Valdecilla University Hospital has led this study. Having established the role of the inactive variant ASCC1, analysis of...
Researchers at the University of Illinois at Chicago College of Medicine have shown for the first time how the activation of a receptor provokes the inflammation and bone degradation of rheumatoid art...